First-in-class dual GIP/GLP-1 receptor co-agonist (twincretin). 39-aa synthetic peptide for dual incretin pathway research, metabolic syndrome studies, and hepatic steatosis models.
Tirzepatide (Mounjaro) is a first-in-class synthetic 39-amino acid dual GIP/GLP-1 receptor co-agonist (twincretin). It simultaneously activates the Glucose-Dependent Insulinotropic Polypeptide receptor (GIPR) and the Glucagon-Like Peptide-1 receptor (GLP-1R), engaging two distinct incretin pathways that converge on pancreatic beta-cell insulin secretion, appetite regulation, and metabolic homeostasis.
SPPS synthesis with fatty acid conjugation; HPLC >=99%; LC-MS confirmed; LAL endotoxin <=1 EU/mg. Full CoA provided.
For Research Use Only. Not for human or veterinary use.
| Product Name | Tirz (Tirzepatide) |
| CAS Number | 2023788-19-2 |
| Purity | ≥99% (by HPLC) |
| Molecular Weight | 4,813.45 g/mol |
| Molecular Formula | C225H348N48O68 |
| Appearance | White to off-white lyophilized powder |
| Storage | Store at -20C desiccated. Stable >=24 months. Reconstituted: use within 7 days at 2-8C. |
| Available Sizes | 10mg · Custom |
Store at -20C desiccated. Stable >=24 months. Reconstituted: use within 7 days at 2-8C.
24 months from manufacture when stored properly.
Cold-chain shipping with ice packs. Express delivery to 35+ countries.
Get premium research-grade peptides with complete documentation and worldwide delivery.
Tirz (Tirzepatide) · CAS 2023788-19-2
Quote request sent! We'll respond within 24 hours.
